Smart Health can be configured to export service records to an external EMR (or SMR). Service records are sent as PDFs in an MDM message.
The first time a service record is exported it is sent in an MDM T02 message (MSH-9 is MDM^T02^MDM_T02). If the service record is updated in Smart Health an update is sent in an MDM T10 message (MSH-9 is MDM^T02^MDM_T02).
OBX-11 is set to P for a draft service record and F for a final service record.
| Service Type (OBX-3.2) | Program | OID (OBX-3.1) | Category (TXA-2) |
|---|---|---|---|
| Admission and Discharge | 1.3.6.1.4.1.30170.2.211 | 51851-4 | |
| Clinical Referral | 1.3.6.1.4.1.30170.2.206 | 34140-4 | |
| Clinical Referral | Cancer | 1.3.6.1.4.1.30170.2.206.11 | 34140-4 |
| Clinical Referral | Cystic Fibrosis | 1.3.6.1.4.1.30170.2.206.1 | 34140-4 |
| Clinical Referral | Homeless Health | 1.3.6.1.4.1.30170.2.206.14 | 34140-4 |
| Clinical Referral | Immunology & ID | 1.3.6.1.4.1.30170.2.206.15 | 34140-4 |
| Clinical Referral | Obstetrics | 1.3.6.1.4.1.30170.2.206.6 | 34140-4 |
| Clinical Referral | Patient Watch | 1.3.6.1.4.1.30170.2.206.16 | 34140-4 |
| Clinical Referral | Renal Disease | 1.3.6.1.4.1.30170.2.206.7 | 34140-4 |
| Consultation Notes | 1.3.6.1.4.1.30170.2.1 | 11488-4 | |
| Dietitian Notes | 1.3.6.1.4.1.30170.2.132 | 11488-4 | |
| Letter | 1.3.6.1.4.1.30170.2.173 | 51852-2 | |
| Letter | Cancer | 1.3.6.1.4.1.30170.2.173.11 | 51852-2 |
| Letter | Cystic Fibrosis | 1.3.6.1.4.1.30170.2.173.1 | 51852-2 |
| Letter | Homeless Health | 1.3.6.1.4.1.30170.2.173.14 | 51852-2 |
| Letter | Immunology & ID | 1.3.6.1.4.1.30170.2.173.15 | 51852-2 |
| Letter | Obstetrics | 1.3.6.1.4.1.30170.2.173.6 | 51852-2 |
| Letter | Patient Watch | 1.3.6.1.4.1.30170.2.173.16 | 51852-2 |
| Letter | Renal Disease | 1.3.6.1.4.1.30170.2.173.7 | 51852-2 |
| Lung Function | 1.3.6.1.4.1.30170.2.72 | 47045-0 | |
| MDT Review | 1.3.6.1.4.1.30170.2.214 | 34794-8 | |
| Occupational Therapy Assessment | 1.3.6.1.4.1.30170.2.133 | 51848-0 | |
| Occupational Therapy Notes | 1.3.6.1.4.1.30170.2.134 | 11488-4 | |
| POS Assessment | 1.3.6.1.4.1.30170.2.213 | 96136-7 | |
| Pathology | 1.3.6.1.4.1.30170.2.3 | 11526-1 | |
| Social Worker Assessment | 1.3.6.1.4.1.30170.2.130 | 51848-0 | |
| CF Diagnosis | Cystic Fibrosis | 1.3.6.1.4.1.30170.2.182 | 11488-4 |
| CF Dietitian Notes | Cystic Fibrosis | 1.3.6.1.4.1.30170.2.41 | 11488-4 |
| CF Examination | Cystic Fibrosis | 1.3.6.1.4.1.30170.2.183 | 11488-4 |
| CF Gastroenterologist Notes | Cystic Fibrosis | 1.3.6.1.4.1.30170.2.79 | 11488-4 |
| CF Nurse Notes | Cystic Fibrosis | 1.3.6.1.4.1.30170.2.38 | 11488-4 |
| CF Occupational Therapist Notes | Cystic Fibrosis | 1.3.6.1.4.1.30170.2.46 | 11488-4 |
| CF Physiotherapist Notes | Cystic Fibrosis | 1.3.6.1.4.1.30170.2.43 | 11488-4 |
| CF Psychiatrist Notes | Cystic Fibrosis | 1.3.6.1.4.1.30170.2.44 | 11488-4 |
| CF Psychologist Notes | Cystic Fibrosis | 1.3.6.1.4.1.30170.2.45 | 11488-4 |
| CF Respiratory Physician Notes | Cystic Fibrosis | 1.3.6.1.4.1.30170.2.37 | 11488-4 |
| CF Social Worker Notes | Cystic Fibrosis | 1.3.6.1.4.1.30170.2.42 | 11488-4 |
| CF Transplant Assessment | Cystic Fibrosis | 1.3.6.1.4.1.30170.2.184 | 51848-0 |
| CF Treatment Status | Cystic Fibrosis | 1.3.6.1.4.1.30170.2.185 | 51851-4 |
| Cystic Fibrosis Action Plan | Cystic Fibrosis | 1.3.6.1.4.1.30170.2.48 | 18776-5 |
| Cystic Fibrosis MDT Review | Cystic Fibrosis | 1.3.6.1.4.1.30170.2.181 | 34794-8 |
| Cystic Fibrosis Physician Assessment | Cystic Fibrosis | 1.3.6.1.4.1.30170.2.69 | 51848-0 |
| Cystic Fibrosis Physiotherapist Assessment | Cystic Fibrosis | 1.3.6.1.4.1.30170.2.66 | 51848-0 |
| Cystic Fibrosis Psychologist Assessment | Cystic Fibrosis | 1.3.6.1.4.1.30170.2.76 | 51848-0 |
| Cystic Fibrosis Social Worker Assessment | Cystic Fibrosis | 1.3.6.1.4.1.30170.2.78 | 51848-0 |
| Extension Line Change | Renal Disease | 1.3.6.1.4.1.30170.2.172 | 28570-0 |
| Falls Risk Assessment | Renal Disease | 1.3.6.1.4.1.30170.2.1018 | 51848-0 |
| Haemodialysis | Renal Disease | 1.3.6.1.4.1.30170.2.58 | 28570-0 |
| Haemodialysis Prescription | Renal Disease | 1.3.6.1.4.1.30170.2.33 | 18776-5 |
| Haemodialysis Review | Renal Disease | 1.3.6.1.4.1.30170.2.29 | 11506-3 |
| Home Peritoneal Dialysis Review | Renal Disease | 1.3.6.1.4.1.30170.2.179 | 11506-3 |
| Peritoneal Dialysis Complication | Renal Disease | 1.3.6.1.4.1.30170.2.176 | 55109-3 |
| Peritoneal Dialysis Prescription | Renal Disease | 1.3.6.1.4.1.30170.2.175 | 18776-5 |
| Peritoneal Dialysis Training | Renal Disease | 1.3.6.1.4.1.30170.2.178 | 11488-4 |
| Peritoneal Equilibration Test and Adequacy | Renal Disease | 1.3.6.1.4.1.30170.2.177 | 11488-4 |
| Peritonitis | Renal Disease | 1.3.6.1.4.1.30170.2.180 | 18776-5 |
| Renal Access Care Plan | Renal Disease | 1.3.6.1.4.1.30170.2.32 | 18776-5 |
| Renal CKD Care Plan | Renal Disease | 1.3.6.1.4.1.30170.2.202 | 18776-5 |
| Renal Clinical Assessment | Renal Disease | 1.3.6.1.4.1.30170.2.57 | 51848-0 |
| Renal Dietitian Notes | Renal Disease | 1.3.6.1.4.1.30170.2.23 | 11488-4 |
| Renal Home Dialysis Assessment | Renal Disease | 1.3.6.1.4.1.30170.2.21 | 51848-0 |
| Renal MDT Review | Renal Disease | 1.3.6.1.4.1.30170.2.212 | 34794-8 |
| Renal Occupational Therapist Notes | Renal Disease | 1.3.6.1.4.1.30170.2.27 | 11488-4 |
| Renal Social Worker Notes | Renal Disease | 1.3.6.1.4.1.30170.2.25 | 11488-4 |
| Renal Supportive Care | Renal Disease | 1.3.6.1.4.1.30170.2.203 | 18776-5 |
| Renal Transplant | Renal Disease | 1.3.6.1.4.1.30170.2.140 | 18776-5 |
| Renal Treatment Status | Renal Disease | 1.3.6.1.4.1.30170.2.118 | 51851-4 |
| Transplant Assessment | Renal Disease | 1.3.6.1.4.1.30170.2.31 | 51848-0 |
| Transplant Waiting List | Renal Disease | 1.3.6.1.4.1.30170.2.153 | 51851-4 |
| Breast Cancer MDT Review | Cancer | 1.3.6.1.4.1.30170.2.163 | 34794-8 |
| Cancer Initial Assessment | Cancer | 1.3.6.1.4.1.30170.2.207 | 51848-0 |
| Central Nervous System Cancer MDT Review | Cancer | 1.3.6.1.4.1.30170.2.170 | 34794-8 |
| Colorectal Cancer MDT Review | Cancer | 1.3.6.1.4.1.30170.2.165 | 34794-8 |
| Endocrine Cancer MDT Review | Cancer | 1.3.6.1.4.1.30170.2.196 | 34794-8 |
| Genito-urinary Cancer MDT Review | Cancer | 1.3.6.1.4.1.30170.2.166 | 34794-8 |
| Gynaecological Cancer Assessment | Cancer | 1.3.6.1.4.1.30170.2.148 | 51848-0 |
| Gynaecological Cancer Complication | Cancer | 1.3.6.1.4.1.30170.2.195 | 11506-3 |
| Gynaecological Cancer Follow-Up | Cancer | 1.3.6.1.4.1.30170.2.194 | 11506-3 |
| Gynaecological Cancer MDT Review | Cancer | 1.3.6.1.4.1.30170.2.159 | 34794-8 |
| Gynaecological Cancer Recurrence | Cancer | 1.3.6.1.4.1.30170.2.192 | 11506-3 |
| Gynaecological Cancer Surgery | Cancer | 1.3.6.1.4.1.30170.2.190 | 11504-8 |
| Haematological Cancer MDT Review | Cancer | 1.3.6.1.4.1.30170.2.171 | 34794-8 |
| Head and Neck Cancer MDT Review | Cancer | 1.3.6.1.4.1.30170.2.169 | 34794-8 |
| Neuroendocrine Cancer MDT Review | Cancer | 1.3.6.1.4.1.30170.2.189 | 34794-8 |
| Sarcoma MDT Review | Cancer | 1.3.6.1.4.1.30170.2.117 | 34794-8 |
| Skin Cancer MDT Review | Cancer | 1.3.6.1.4.1.30170.2.167 | 34794-8 |
| Thoracic Cancer MDT Review | Cancer | 1.3.6.1.4.1.30170.2.164 | 34794-8 |
| Upper Gastrointestinal Cancer MDT Review | Cancer | 1.3.6.1.4.1.30170.2.168 | 34794-8 |
| Advanced Liver Disease Assessment | Immunology & ID | 1.3.6.1.4.1.30170.2.145 | 51848-0 |
| Anoscopy/Peri-anal Exam | Immunology & ID | 1.3.6.1.4.1.30170.2.162 | 11488-4 |
| HIV Assessment | Immunology & ID | 1.3.6.1.4.1.30170.2.121 | 51848-0 |
| Hepatitis Assessment | Immunology & ID | 1.3.6.1.4.1.30170.2.142 | 51848-0 |
| Hepatitis C Care Plan | Immunology & ID | 1.3.6.1.4.1.30170.2.143 | 18776-5 |
| Immunology & ID Neuropsychology Notes | Immunology & ID | 1.3.6.1.4.1.30170.2.135 | 11488-4 |
| Immunology & ID Social Worker Notes | Immunology & ID | 1.3.6.1.4.1.30170.2.131 | 11488-4 |
| Immunology A Assessment | Immunology & ID | 1.3.6.1.4.1.30170.2.147 | 51848-0 |
| Immunology A Care Plan | Immunology & ID | 1.3.6.1.4.1.30170.2.150 | 18776-5 |
| Infectious Diseases Assessment | Immunology & ID | 1.3.6.1.4.1.30170.2.146 | 51848-0 |
| Infectious Diseases Care Plan | Immunology & ID | 1.3.6.1.4.1.30170.2.149 | 18776-5 |
| PEP Assessment | Immunology & ID | 1.3.6.1.4.1.30170.2.122 | 51848-0 |
| PEP Care Plan | Immunology & ID | 1.3.6.1.4.1.30170.2.123 | 18776-5 |
| Covid Questionnaire | Patient Watch | 1.3.6.1.4.1.30170.2.1016 | 34109-9 |
| Initial Assessment | Patient Watch | 1.3.6.1.4.1.30170.2.1017 | 51848-0 |
| Patient Watch Assessment | Patient Watch | 1.3.6.1.4.1.30170.2.198 | 51848-0 |
| Patient Watch Care Plan | Patient Watch | 1.3.6.1.4.1.30170.2.200 | 18776-5 |
| Patient Watch Health Journey Check Status | Patient Watch | 1.3.6.1.4.1.30170.2.210 | 51851-4 |
| Patient Watch MDT Review | Patient Watch | 1.3.6.1.4.1.30170.2.208 | 34794-8 |
| Patient Watch Outreach Risk Assessment | Patient Watch | 1.3.6.1.4.1.30170.2.201 | 51848-0 |
| Patient Watch Periodic Review | Patient Watch | 1.3.6.1.4.1.30170.2.205 | 11506-3 |
| Patient Watch Problem and Action | Patient Watch | 1.3.6.1.4.1.30170.2.193 | 18776-5 |
| Patient Watch Profile | Patient Watch | 1.3.6.1.4.1.30170.2.199 | 51848-0 |
| Patient Watch Questionnaire - Health Journey Check | Patient Watch | 1.3.6.1.4.1.30170.2.204 | 34109-9 |
| Patient Watch Questionnaire - Mini Health Check | Patient Watch | 1.3.6.1.4.1.30170.2.209 | 34109-9 |
| Patient Watch Treatment Status | Patient Watch | 1.3.6.1.4.1.30170.2.191 | 51851-4 |
| Progress Note | Patient Watch | 1.3.6.1.4.1.30170.2.1015 | 11506-3 |